ELITE PHARMACEUTICALS INC /NV/ financial data

Symbol
ELTP on OTC
Location
Northvale, NJ
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 685% % 112%
Quick Ratio 170% % 52%
Debt-to-equity 86% % 13%
Return On Equity 71% %
Return On Assets 38% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,076,996,442 shares 0.82%
Common Stock, Shares, Outstanding 1,074,496,442 shares 0.58%
Entity Public Float $323,296,443 USD 240%
Common Stock, Value, Issued $1,074,600 USD 0.58%
Weighted Average Number of Shares Outstanding, Basic 1,074,115,101 shares 0.55%
Weighted Average Number of Shares Outstanding, Diluted 1,140,876,178 shares 6.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $140,118,325 USD 100%
Cost of Revenue $68,571,039 USD 75%
Research and Development Expense $6,142,348 USD -20%
General and Administrative Expense $11,934,035 USD 30%
Operating Income (Loss) $50,080,055 USD 311%
Nonoperating Income (Expense) $5,151,693 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $55,231,748 USD
Income Tax Expense (Benefit) $239,175 USD
Net Income (Loss) Attributable to Parent $43,409,235 USD
Earnings Per Share, Basic 0.04 USD/shares
Earnings Per Share, Diluted 0.03 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,106,262 USD -9.3%
Accounts Receivable, after Allowance for Credit Loss, Current $48,529,574 USD 163%
Inventory, Net $25,099,135 USD 25%
Assets, Current $96,789,871 USD 101%
Deferred Income Tax Assets, Net $10,325,353 USD -50%
Property, Plant and Equipment, Net $10,035,389 USD 1.7%
Operating Lease, Right-of-Use Asset $1,651,592 USD -22%
Assets $126,412,637 USD 39%
Accounts Payable, Current $6,522,108 USD 12%
Employee-related Liabilities, Current $206,225 USD
Accrued Liabilities, Current $5,547,783 USD 49%
Contract with Customer, Liability, Current $2,222 USD -83%
Liabilities, Current $13,187,179 USD -10%
Contract with Customer, Liability, Noncurrent $2,222 USD -86%
Operating Lease, Liability, Noncurrent $1,157,161 USD -31%
Liabilities $46,098,554 USD -15%
Retained Earnings (Accumulated Deficit) $94,292,428 USD 32%
Stockholders' Equity Attributable to Parent $80,314,083 USD 120%
Liabilities and Equity $126,412,637 USD 39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,775,842 USD 370%
Net Cash Provided by (Used in) Financing Activities $4,130,684 USD -2262%
Net Cash Provided by (Used in) Investing Activities $218,204 USD 87%
Common Stock, Shares Authorized 1,445,000,000 shares 0%
Common Stock, Shares, Issued 1,074,596,442 shares 0.58%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,426,954 USD 698%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21,562,479 USD 147%
Interest Paid, Excluding Capitalized Interest, Operating Activities $158,926 USD -29%
Deferred Tax Assets, Gross $20,073,000 USD -17%
Operating Lease, Liability $1,676,900 USD -21%
Depreciation $1,226,399 USD -7.1%
Payments to Acquire Property, Plant, and Equipment $218,204 USD -72%
Property, Plant and Equipment, Gross $27,883,555 USD 4.8%
Operating Lease, Liability, Current $519,739 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $667,307 USD 2.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) $4,884,535 USD 26725%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $262,354 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $666,207 USD -0.16%
Deferred Tax Assets, Operating Loss Carryforwards $10,664,000 USD -31%
Current Income Tax Expense (Benefit) $468,000 USD 36%
Lessee, Operating Lease, Liability, to be Paid, Year Four $440,159 USD -34%
Additional Paid in Capital $173,838,752 USD 0.26%
Depreciation, Depletion and Amortization $1,183,346 USD -14%
Deferred Tax Assets, Net of Valuation Allowance $24,293,000 USD 1018%
Share-based Payment Arrangement, Expense $199,672 USD -12%
Interest Expense $588,622 USD -47%